IGEA Pharma NV
F:3B5

Watchlist Manager
IGEA Pharma NV Logo
IGEA Pharma NV
F:3B5
Watchlist
Price: 16.791 EUR -3.07% Market Closed
Market Cap: 10.6m EUR

Intrinsic Value

3B5 price has not been updated for more than 5 years. This may indicate that the stock has been delisted.
3B5 doesn't have a meaningful market cap.

There is not enough data to reliably calculate the intrinsic value of 3B5.

The Intrinsic Value is calculated as the average of DCF and Relative values:

3B5 Intrinsic Value
Not Available
Base Case Scenario
Compare 3B5 to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about IGPH?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
IGEA Pharma NV

Current Assets 105.2k
Cash & Short-Term Investments 66k
Receivables 39.2k
Current Liabilities 669k
Accounts Payable 436.5k
Other Current Liabilities 232.5k
Non-Current Liabilities 489.7k
Long-Term Debt 510k
Other Non-Current Liabilities -20.3k
Efficiency

Free Cash Flow Analysis
IGEA Pharma NV

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
IGEA Pharma NV

Revenue
0 EUR
Operating Expenses
-335.6k EUR
Operating Income
-335.6k EUR
Other Expenses
1.7m EUR
Net Income
1.3m EUR
Fundamental Scores

3B5 Profitability Score
Profitability Due Diligence

IGEA Pharma NV's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional ROE
ROE is Increasing
ROIC is Increasing
Negative 3Y Average Gross Margin
hidden
Profitability
Score

IGEA Pharma NV's profitability score is hidden . The higher the profitability score, the more profitable the company is.

3B5 Solvency Score
Solvency Due Diligence

IGEA Pharma NV's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Positive Net Debt
Short-Term Solvency
Long-Term Solvency
hidden
Solvency
Score

IGEA Pharma NV's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

3B5 Price Targets Summary
IGEA Pharma NV

There are no price targets for 3B5.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for IGPH is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

IGPH Insider Trading
Buy and sell transactions by insiders